Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results (Q68433186)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1990

Language	Label	Description	Also known as
English	Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results	scientific article published on 01 December 1990

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

based on heuristic

inferred from title

author name string

P L Venturini

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

V Fasce

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

S Costantini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

P Anserini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

S Cucuccio

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

L de Cecco

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

language of work or name

0 references

publication date

1 December 1990

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1021-1027

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

The Treatment of Endometriosis by Inducing Pseudopregnancy with Ovarian Hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Clinical Studies with an Antigonadotropin-Danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Gestrinone versus danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotrophin hormone releasing hormone agonist--Nafarelin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2953999-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(16)53999-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2147154%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68433186&oldid=2224647933"